Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Is Pursuing Its Own Pharma Fraud Investigations; DoJ Nets $2.5 Bil. In FY 2010

Executive Summary

One sign that the government is zealously going after the pharmaceutical industry for health care fraud is the line up of criminal investigations FDA has initiated.

You may also be interested in...

FDA Opened 16 Health Care Fraud Investigations In FY 2011; DoJ Net Tops $4 Billion

HHS and the Department of Justice note actions taken last year in their Health Care Fraud and Abuse Control Program Annual Report for fiscal year 2011; enforcement actions net a record sum.

Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First

FDA appears likely to target flagrant off-label promotion in its first cases under new procedures for using the Park Doctrine and strict liability statutes to prosecute corporate executives and others.

Novartis Settlement Encompasses Whistleblower Claims Of Kickbacks For Diovan Prescribing

The company agrees to pay $422.5 million to resolve civil and criminal claims related to off-label use and kickbacks, including allegations that it paid doctors' speaking and consulting fees based upon the volume of prescriptions they wrote for its hypertension drugs.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts